Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.37% | 242.40 | 1.5% | $875.87m | |
| MRNA | Moderna, Inc. | 5.12% | 150.17 | 0.0% | $811.88m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.28% | 282.59 | 1.9% | $481.19m | |
| GILD | Gilead Sciences, Inc. | -0.32% | 61.61 | 1.0% | $473.86m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.42% | 588.64 | 2.6% | $469.68m | |
| NVAX | Novavax, Inc. | 10.77% | 56.97 | 75.7% | $441.45m | |
| ILMN | Illumina, Inc. | 1.55% | 187.22 | 3.3% | $341.07m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -1.03% | 3.84 | 0.7% | $268.43m | |
| BIIB | Biogen, Inc. | 1.24% | 206.46 | 1.8% | $241.01m | |
| BNTX | BioNTech SE | 4.15% | 155.28 | 0.0% | $194.91m | |
| CRSP | CRISPR Therapeutics AG | 3.36% | 62.81 | 0.6% | $165.46m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.70% | 83.45 | 4.2% | $116.99m | |
| EXAS | EXACT Sciences Corp. | 2.45% | 40.36 | 17.7% | $93.17m | |
| IOVA | Iovance Biotherapeutics, Inc. | 2.94% | 11.37 | 0.0% | $90.74m | |
| TECH | Bio-Techne Corp. | 0.41% | 348.05 | 4.5% | $89.98m |
Company Profile
Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which treats cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. Its product pipeline includes JTX-2011 (ICOS), JTX-4014 (PD-1), the Lead Macrophage Program, Macrophage Targeting, T Reg, B Cells, and Stromal Targeting. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA.